Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 366

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

Open access
Martin, Paul J., Counts, George W., Appelbaum, Frederick R., Lee, Stephanie J., Sanders, Jean E., Deeg, H. Joachim, Flowers, Mary E.D., Syrjala, Karen L., Hansen, John A., Storb, Rainer F., Storer, Barry E.·2010·Journal of Clinical Oncology

Abstract

Purpose: Hematopoietic cell transplantation can cure hematologic malignancies and other diseases, but this treatment can also cause late complications. Previous studies have evaluated the cumulative effects of late complications on survival, but longer-term effects on life expectancy after hematopoietic cell transplantation have not been assessed. Patients and Methods: We used standard methods to evaluate mortality, projected life expectancy, and causes of death in a cohort of 2,574 patients who survived without recurrence of the original disease for at least 5 years after allogeneic or autologous hematopoietic cell transplantation from 1970 through 2002. Sex- and age-specific comparisons were made with US population data. Results: Estimated survival of the cohort at 20 years after transplantation was 80.4% (95% CI, 78.1% to 82.6%). During 22,923 person-years of follow-up, 357 deaths occurred. Mortality rates remained four- to nine-fold higher than the expected population rate for at least 30 years after transplantation, yielding an estimated 30% lower life expectancy compared with that in the general population, regardless of current age. In rank order, the leading causes of excess deaths were second malignancies and recurrent disease, followed by infections, chronic graft-versus-host disease, respiratory diseases, and cardiovascular diseases. Conclusion: Patients who have survived for at least 5 years after hematopoietic cell transplantation without recurrence of the original disease have a high probability of surviving for an additional 15 years, but life expectancy is not fully restored. Further effort is needed to reduce the burden of disease and treatment-related complications in this population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2009.25.6693

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 366

Metadata

Authors
Martin, P. J., Counts, G. W., Appelbaum, F. R., Lee, S. J., Sanders, J. E., Deeg, H. J., Flowers, M. E. D., Syrjala, K. L., Hansen, J. A., Storb, R. F., & Storer, B. E.
Venue
Journal of Clinical Oncology
Published
2010-02-20
Volume
28
Issue
6
Pages
1011-1016
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2137266530
Cited by
366
References
20
FWCI
12.03
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation. https://app.cochat.ai/papers/10.1200/jco.2009.25.6693
The paper
Martin, P. J., Counts, G. W., Appelbaum, F. R., Lee, S. J., Sanders, J. E., Deeg, H. J., Flowers, M. E. D., Syrjala, K. L., Hansen, J. A., Storb, R. F., & Storer, B. E. (2010). Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2009.25.6693

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.